BL 323 (Relcof IR guaifenesin 380 mg / phenylephrine hydrochloride 10 mg)
Generic Name: guaifenesin/phenylephrine
Pill with imprint BL 323 is White, Elliptical / Oval and has been identified as Relcof IR guaifenesin 380 mg / phenylephrine hydrochloride 10 mg. It is supplied by Burel Pharmaceuticals, Inc..
Relcof IR is used in the treatment of cough and nasal congestion; sinus symptoms and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Relcof IR guaifenesin 380 mg / phenylephrine hydrochloride 10 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BL 323
- Generic Name
- BL 323
- guaifenesin 380 mg / phenylephrine hydrochloride 10 mg
- 17.00 mm
- Elliptical / Oval
- Rx and/or OTC
- Drug Class
- Upper respiratory combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Burel Pharmaceuticals, Inc.
- National Drug Code (NDC)
- Inactive Ingredients
silicon dioxide, croscarmellose sodium, hypromelloses, maltodextrin, povidone, microcrystalline cellulose, stearic acid
Note: Inactive ingredients may vary.
More about Relcof IR (guaifenesin / phenylephrine)
- Side Effects
- During Pregnancy
- Dosage Information
- Imprints, Shape & Color Data
- Drug Interactions
- Drug class: upper respiratory combinations
- FDA Alerts (1)
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.